Active Biotech: Rights Issue of SEK35m

Research Note

2024-09-23

15:15

Redeye comments on Active Biotech’s rights issue of SEK35m with a subscription price of SEK 0.0415.

RR

Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.